Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Nov 14, 2018

SELL
$10.92 - $18.18 $369,227 - $614,702
-33,812 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$10.0 - $17.87 $120,000 - $214,440
12,000 Added 55.02%
33,812 $512,000
Q1 2018

May 14, 2018

BUY
$9.36 - $15.22 $58,050 - $94,394
6,202 Added 39.73%
21,812 $294,000
Q4 2017

Feb 14, 2018

BUY
$8.48 - $12.0 $132,372 - $187,320
15,610
15,610 $152,000

Others Institutions Holding OBSV

About ObsEva SA


  • Ticker OBSV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,499,200
  • Description
  • ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. It is developing Linzagolix, an oral gonadotropin releasing hormone receptor antagonist that is in Phase III clinical trial for the treatment of pain associated with endometrio...
More about OBSV
Track This Portfolio

Track Drw Securities, LLC Portfolio

Follow Drw Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Drw Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Drw Securities, LLC with notifications on news.